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Lyme borreliosis, caused by the spirochete Borrelia burgdorferi sensu lato, has grown into a major public health problem. We recently identified a novel morphological form of B. burgdorferi, called biofilm, a structure that is well known to be highly resistant
to antibiotics. However, there is no evidence of the existence of Borrelia biofilm in vivo; therefore, the main goal of this study was
to determine the presence of Borrelia biofilm in infected human skin tissues. Archived skin biopsy tissues from borrelial lymphocytomas (BL) were reexamined for the presence of B. burgdorferi sensu lato using Borrelia-specific immunohistochemical staining
(IHC), fluorescent in situ hybridization, combined fluorescent in situ hybridization (FISH)–IHC, polymerase chain reaction (PCR),
and fluorescent and atomic force microscopy methods. Our morphological and histological analyses showed that significant
amounts of Borrelia-positive spirochetes and aggregates exist in the BL tissues. Analyzing structures positive for Borrelia showed
that aggregates, but not spirochetes, expressed biofilm markers such as protective layers of different mucopolysaccharides, especially alginate. Atomic force microscopy revealed additional hallmark biofilm features of the Borrelia/alginate-positive aggregates
such as inside channels and surface protrusions. In summary, this is the first study that demonstrates the presence of Borrelia biofilm in human infected skin tissues.
Keywords: Lyme disease, biofilm, mucopolysaccharides, alginate, atomic force microscopy
Abbreviations: AEC, 3-amino-9-ethylcarbazole; ATCC, American Type Culture Collection; AFM, atomic force microscopy;
BL, borrelial lymphocytoma; BSA, bovine serum albumin; BSK-H, Barbour–Stoner–Kelly H; DAPI, 4´,6-diamidino-2-phenylindole; DIC, differential interference contract microscopy; EDTA, ethylenediaminetetraacetic acid; FAM, 6-fluorescein amidite;
FFPE, formalin-fixed, paraffin-embedded; FISH, fluorescent in situ hybridization; FITC, fluorescein isothiocyanate; H&E, hematoxylin and eosin; IRB, Institutional Review Board; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; RT, room
temperature; SSC, saline sodium citrate

Introduction
Lyme disease, transmitted by the bite of infected ticks of
the Ixodes genus, is an infectious disease caused by spirochetes belonging to the genus Borrelia [1]. Lyme disease
is estimated to affect 300,000 people a year in the United
States and 65,000 people per year in Europe [2].
Lyme disease patients are treated with various antibiotics though the rates of relapse and recurrence of the
disease are frequent after discontinuing the antibiotic treatment [3–7]. It was proposed earlier that the observed antibiotic resistance and reoccurrence of Lyme disease might
be due to the formation of defensive morphological forms
of Borrelia burgdorferi [8–10].

In addition to its familiar spirochete form, B. burgdorferi can transform from motile spirochetes into round
body forms in the presence of various unfavorable environmental conditions including the presence of antimicrobial agents [11–17]. The presence of those alternative
forms was confirmed with numerous in vitro and in vivo
studies; it was also proven that they respond to different
antibiotic treatments than the spirochetal forms [18–22].
However, despite the fact that we might have good understanding about the effective treatment for those known
alternative forms, in vivo studies still reported an uncultivable but infective form of B. burgdorferi, which could
evade even the most aggressive antimicrobial treatments
[23–26].
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Searching for potential answers for the observed high
antibiotic resistance in vivo, we identified that this bacterium has an additional morphological form, called biofilm,
a form which is very well known for allowing the bacteria
to survive in adverse environmental conditions [27–31].
We provided evidence for the in vitro existence of borrelial
biofilm using several known hallmark biofilm features including structural rearrangements in the aggregates producing a complex structure with channel and protrusions,
a common feature in biofilm forming Pseudomonas aeruginosa, Azotobacter vinelandii, and Leptospira biflexa
[32–37]. We also provided evidence that B. burgdorferi
sensu stricto and sensu lato aggregates have specific surface biofilm markers such as alginate [30, 38], a mucopolysaccharide which is well characterized in biofilms of
other pathogenic bacteria [39].
In addition, we and others have demonstrated that
B. burgdorferi aggregate formation enhances the antibiotic resistance of the organism to various antibiotics, which
previously showed some success against the spirochete
and round body forms of B. burgdorferi [20–22, 40]. Taken together, these in vitro observations of biofilm formation suggest that B. burgdorferi could play significant role
in their survival in diverse environmental conditions, by
providing refuge to individual cells. However, the question
remains if these structures can be found in vivo and whether these biofilm structures hold significant relevance for
the survival strategies for Borrelia spp. in infected tissues.
In order to answer this question, we reexamined the
findings from our earlier studies where we have seen similar Borrelia aggregates in infected skin tissues. We previously investigated different infected biopsy sections from
known cutaneous complication of Lyme disease such as
erythema chronicum migrans, borrelial lymphocytoma,
and Borrelia acrodermatitis chronica atrophicans for the
presence of Borrelia-positive structures [41]. We observed
individual spirochetes in the sections as well as putative
aggregates especially in the borrelial lymphocytoma (BL)
tissues. These structures are strikingly similar to the ones
we have previously seen and characterized in our in vitro
culture systems that were proven to be biofilm [30].
Borrelial lymphocytoma, which develops weeks to
months after the tick bite, is a rare but typical manifestation
of Lyme disease found mainly in Europe [41, 42]. Because
the low sensitivity of the available serology and molecular
biology techniques, clinical diagnosis for BL still relies on
clinical presentation and histological examination of the
infected tissues [41, 42]. For example, histologic examination of cutaneous borrelial infections, including BL, usually reveals an infiltrate of lymphocytes, macrophages, and
plasma cells in cutaneous lesions with “acral” predilection
which are very characteristic of BL [41, 42].
Therefore, in this study, we used BL skin biopsies to
evaluate whether the surface of Borrelia-positive aggregates could contain different mucopolysaccharides, especially alginate, to provide evidence for the existence of
Borrelia biofilm in vivo. First, we used Borrelia-specific
immunohistochemical (IHC), fluorescent in situ hybridEuropean Journal of Microbiology and Immunology

ization (FISH), and polymerase chain reaction (PCR) techniques to find Borrelia spirochetes and aggregates in the
archived tissue biopsies from BL cases. We then further
analyzed the surface of Borrelia-positive aggregates for
potential mucopolysaccharides using different histological, IHC, combined IHC–FISH, and atomic force microscopy methods to further analyze those Borrelia/alginatepositive structures.

Materials and methods
Human tissue samples, processing biopsy specimens
From the files of our dermatohistopathologic laboratory,
archived paraffin materials were retrieved from January
1975 to December 2005 from six cases of clinically confirmed borrelial lymphocytoma by certified dermatopathologists. All six cases had positive serology for Borrelia
IgG, and characteristic features of borrelial lymphocytoma
with “acral” predilection were found. All six patients were
female (average age = 33 years) from endemic areas of
Borreliosis in Austria with a rate of positive serology in the
population between 30 and 60%. PCR confirmation for all
six cases were performed independently in two different
laboratories located in Austria and the US. The archival
hematoxylin and eosin (H&E)-stained sections were reexamined, and the previous diagnosis also confirmed by
two of us (B.Z. and A.M.D.). Institutional Review Board
(IRB) exemption for this study was obtained from University of New Haven.
The paraffin blocks were sectioned by McClain Laboratories LLC (Smithtown NY) at 4 μm on TRUBOND200
adhesive slides. The sections then were deparaffinized by
washing the sections three times in 100% xylene for 5 min
each followed by rehydration in a series of graded alcohols (100%, 90%, and 70%) and washed in 1× phosphatebuffered saline (PBS) pH 7.4 for 5 min. For the immunohistochemical experiments, the tissues were incubated in
10 mM sodium citrate buffer for 45 min at 95 °C for antibody retrieval for the immunohistochemical experiments.
For silver penetration method, the modified Dieterle method was used by the McClain Histopathology Laboratories
LLC (Smithtown NY) following a previously published
procedure by Duray P. et al. [43].

Bacterial cultures
Low passage isolates (<p3) of B. burgdorferi B31 (ATCC
no. 35210), Borrelia garinii (ATCC no. 51991), Borrelia afzelii (ATCC no. 51992), and Treponema denticola (ATCC
no. 33520) were obtained from American Type Culture
Collection (ATCC). Borrelia hermsii was received from
Dr. Tom G. Schwan’s laboratory at Rocky Mountain Laboratories, NIH. Cells were maintained in Barbour–Stoner–Kelly H (BSK-H, Sigma) media supplemented with
6% or 12% (for T. denticola and B. hermsii) rabbit serum
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(Pel-Freeze) without antibiotics in sterile 15 ml glass tubes
and incubated at 33 °C with 5% CO2. Escherichia coli biofilm forming strain was obtained from ATCC (ATCC no.
25922) and cultured overnight at 37 °C with shaking at
200 rpm in sterile 50 ml centrifuge tubes containing Luria
broth media (Difco).
Slide preparation for in vitro experiments
Cell concentrations were determined using the PetroffHausser counting chamber method. A total of 1 × 106 cells
per milliliter were centrifuged at 4000×g for 10 min at
room temperature (RT) to remove the media. The supernatant was discarded, pellet was washed two times with
1 ml of 1× PBS (pH 7.4) and then resuspended in 100 μl
of 1× PBS (pH 7.4), and the samples were smeared onto
glass microscope slides (Superfrost+, Thermo Scientific).
The smear was allowed to completely dry in a laminar airflow chamber, followed by fixation with ice-cold acetone
for 15 min. Slides were then washed twice with 1× PBS
(pH 7.4) at RT and used for the experiments.

Immunohistochemistry methods (IHC)
Two independent immunohistochemistry methods were
performed as described before [30, 41]. Initially, the archived BL biopsy samples were immunostained with
Borrelia-specific antibody to confirm the presence of Borrelia spp. in Innsbruck Medical University, utilizing the
Ventana-KIT (Ventana Medical Systems, Munich, Germany). In this method, a biotinylated secondary antibody
and a third layer of streptavidin–biotin horseradish peroxidase complex were utilized. As a final reaction product,
3-amino-9-ethylcarbazole (AEC) was used with bright red
which proved to be superior to the brown diaminobenzidine. Negative control experiments were performed by
omitting the primary antibody in an otherwise identical
immunohistochemical procedure.
To further confirm the presence of Borrelia spp. in
these tissues, the immunostaining was repeated at the University of New Haven using a previously published immunofluorescence protocol [30]. The Borrelia–alginate double staining IHC was performed in two different ways. On
the same slides using the primary antibodies sequentially
or consecutive slides using the two primary antibodies in
parallel to provide information whether the two primary
antibodies would have cross-reaction with the corresponding secondary antibodies. On the same slide method, the
deparaffinized BL sections were first blocked with 10%
normal goat serum (Thermo Scientific) in 1× PBS pH (7.4)
for 30 min at RT to block nonspecific binding of the secondary antibody. The slides were then washed two times
with PBS/0.5% bovine serum albumin (BSA) for 5 min
each and further incubated at 37 °C for 1 h with fluorescein isothiocyanate (FITC)-labeled Borrelia-specific polyclonal antibody (#73005 Thermo Scientific, diluted 1:50 in
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1× PBS/0.5% BSA). The slides were washed with 1× PBS
five times for 5 min each at RT and counterstained with Sudan black (Sigma) and/or 4´,6-diamidino-2-phenylindole
(DAPI) for 10 min. The slides were washed again with 1×
PBS for 5 min, dried and mounted with PermaFluor aqueous mounting medium (Thermo Scientific). Images were
acquired by fluorescent microscopy (Leica DM2500). On
immunostaining method on sequential slides, the two primary antibodies were used in parallel experiment. For the
IHC, two additional negative controls were used: 1) omitting primary antibody (use only 1× PBS + 0.5% BSA) and
2) normal human foreskin samples purchased commercially.

Spicer & Meyer mucopolysaccharide staining
The staining was performed as described previously with
minor modifications [30]. Briefly, Borrelia aggregates on
the deparaffinized and hydrated BL biopsy sections were
stained with aldehyde fuchsine solution (Sigma-Aldrich,
0.5% fuchsine dye, 6% acetaldehyde in 70% ethanol with
1% concentrated hydrochloric acid) for 20 min. After immersing the slides in 70% ethanol for 1 min and having
it rinsed with double-distilled water for another minute,
the aggregates were sequentially stained with 1% Alcian
blue 8GX (Sigma-Aldrich, dissolved in 3% acetic acid,
pH 2.5) for 30 min. The slides were rinsed with double distilled water for 3 min and dehydrated using chilled graded
ethanol washes (50%, 70%, and 95%, 3 min each). The
slides were then immersed in chilled xylene for 2 min and
mounted with Permount media (Fisher Scientific). Images
were analyzed using different microscopy methods (see
Results section).

Genomic DNA extraction
Genomic DNA was extracted from B. afzelii BO23 laboratory strain (ATCC no. 51992) using Qiagen DNeasy Blood
and Tissue Kit (Qiagen) according to the manufacturer’s
instructions. All samples were stored at −20 °C until analysis. Genomic DNA from paraffin-embedded tissues fixed
on glass slides was extracted using the Qiagen QIAamp
DNA Formalin-fixed, Paraffin-Embedded (FFPE) Tissue
Kit (Qiagen). First, the slides were deparaffinized, and
then any tissues present on the slides were scraped off using sterile blades and collected in sterile microcentrifuge
tubes. One hundred eighty microliters of ATL buffer and
20 μl of proteinase K were added to the tubes, and the samples were incubated overnight at 42 °C and then at 90 °C
for 1 h to deactivate the enzyme. Two hundred microliters of AL buffer and an additional 200 μl of 96% ethanol
were added to the samples and vortexed thoroughly. The
samples were then transferred to DNeasy mini columns
and centrifuged for 1 min at 6000×g. The flow-through
was discarded, and the columns were placed into new
collection tubes. To wash away any unwanted materials
European Journal of Microbiology and Immunology
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that might be present along with the DNA, 500 μl of AW1
and AW2 buffers was added to the columns consecutively
and centrifuged at 6000×g for 1 min. The spin columns
were placed then in fresh collection tubes and centrifuged
at 20,000×g for 3 min to completely dry the column. The
columns were then placed in new microcentrifuge tubes,
and the samples were eluted twice with 50 μl of ATE buffer. The samples were quantified using BioTek Microplate
Spectrophotometer (BioTek) and stored at −20 °C until
analysis.

PCR/DNA sequencing
PCR reactions were performed using primers designed
to amplify B. burgdorferi sensu lato 16S ribosomal RNA
small subunit. The 16S rRNA gene was amplified in a single reaction using primers F: 5´-CCTGGCTTAGAACTAACG-3´ and R: 5´-CCTACAAAGCTTATTCCTCAT-3´
in a 50-μl reaction containing HotStarTaq buffer (Qiagen)
1.5 mM MgCl2, 25 pmoles of each primer, and 2.5 units of
HotStarTaq DNA polymerase (Qiagen). The PCR reaction
consisted of an initial denaturation at 94 °C for 15 min, followed by 40 cycles of 94 °C/30 s, 50 °C/30 s, 72 °C/1 min,
and then a final extension at 72 °C/5 min. The PCR products were analyzed by standard agarose gel electrophoresis. PCR products were purified using the QIAquick PCR
purification kit (Qiagen) according to the manufacturer’s
instructions. Samples were eluted twice in 30 μl, and the
eluates from each sample were pooled and sequenced in
both directions twice (4× coverage) using the same primers that generated the products. All DNA sequencings were
performed by Eurofins/MGW/Operon (Huntsville, AL).
Fluorescent in situ hybridization (FISH)
A 32-base-long oligonucleotide probe was designed for
B. burgdorferi sensu lato species-specific 16S ribosomal DNA (5´-GGATATAGTTAGAGATAATTATTCCCCGTTTG-3´). The probe was designed to hybridize with
B. burgdorferi, B. garinii, and B. afzelii, but not with T. denticola and E. coli strains (see validation study below). As
a negative control, a 32-base-long random oligonucleotide
probe (5´-GCATAGACATGAGATATACTGTACTAG-3´)
was also designed. Both probes were synthesized and labeled with 6-fluorescein amidite (FAM) at the 5´ end by
Eurofins MWG Operon oligonucleotide services. In situ
hybridization probes were prepared by mixing 100 ng of
labeled oligonucleotide with 2.5 μg salmon sperm DNA
(Life Technologies) plus with 0.1 volume 3M sodium acetate (Fisher Scientific) and 2 volumes of ice cold ethanol,
and the mixture was allowed to precipitate at −80 °C for
1 h. Probes were then centrifuged at 14,000 rpm for 20 min
and resuspended in 10 μl hybridization buffer (50% v/v formamide [Sigma], 10% w/v dextran sulfate [Sigma], 1% v/v
Triton X-100 [Sigma], and 2× saline sodium citrate [SSC]
pH 7.0). Probes were then warmed to RT for 10 min, denaEuropean Journal of Microbiology and Immunology

tured at 95 °C for 10 min, and immediately cooled on ice
for 10 min. Slides containing fixed cells were denatured in
denaturing solution (70% v/v formamide, 2× SSC, 0.1 mM
ethylenediaminetetraacetic acid [EDTA] pH 7.0) at 70 °C
for 5 min and washed twice with cold 2× SSC followed by
dehydration through a series of cold alcohol washes (70%,
90%, 100%). The sections were hybridized with the probe
in the dark at 48 °C for 24 h. After hybridization, slides
were washed three times with 2× SSC for 3 min each at RT
followed by two 20 min washes in 0.1× SSC at 42 °C and a
final wash in 0.1× SSC at RT. Finally, slides were blocked
with freshly made blocking solution (3% w/v BSA [Fisher]
in 4× SSC, 0.1% v/v Triton X-100) for 3 min and washed
with a wash solution (4× SSC, 0.1 % v/v Triton X-100) for
3 min at room temperature.
For the paraffin-embedded tissue sections, the slides
were first deparaffinized by heating on a slide warmer for
40 min at 45 °C and immersed in 100% xylene for 5 min
three times. The slides were rehydrated in series of graded
alcohols (100%, 90%, and 70%) and washed in PBS for
5 min and in distilled water for 15 min to rehydrate the
tissues. The slides were treated with 4% sodium borohydride (Sigma-Aldrich) for 20 min on ice. The tissues were
digested with prewarmed proteinase K solution (20 μg/ml
in 50 mM Tris) for 10 min at 37 °C and refixed with 4%
paraformaldehyde for 10 min at room temperature. The
slides were denatured using preheated denaturing buffer
(70% v/v formamide, 2× SSC, and 0.1 mM EDTA [Fisher]
pH 7) at 70 °C followed by prehybridization for 4 h in hybridization buffer (50% v/v formamide [Sigma], 10% w/v
dextran sulfate [Sigma], 1% v/v Triton X-100 [Sigma], 2×
SSC, [Sigma] pH 7.0, and 2 ng of salmon sperm DNA)
in an incubator at 48 °C. The sections were hybridized
with the probe at 48 °C for 18 h in dark. After hybridization, slides were washed three times with 2× SSC for 3
min each at room temperature followed by five 20 min
washes in 0.1× SSC at 42 °C and a final wash in 2× SSC
at room temperature. Finally, slides were blocked with
freshly made blocking solution (3% w/v BSA [Fisher] in
4× SSC, 0.1% v/v Triton X-100) for 30 min and washed
with wash solution (4× SSC, 0.1 % v/v Triton X-100) for
3 min at room temperature. All steps were repeated with
several controls such as: 1) 100 ng negative control random oligonucleotide, 2) 200 ng of unlabeled competing
oligonucleotide present during the hybridization, and
3) following a DNase treatment of the sections before the
hybridization step to digest all genomic DNA (100 μg/
ml for 60 min at 37 °C). All slides were then analyzed by
fluorescent microscopy using a Leica DM2500 biomedical microscope.

Combined FISH and IHC analyses
For the paraffin-embedded tissue sections, slides were
first deparaffinized, rehydrated, and pretreated, and in situ
hybridization protocol was followed as described above
in the FISH section. After the last 0.2× SSC wash, the
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sections were blocked with a 1:100 dilution of goat serum (Thermo Scientific) in 1× PBS pH 7.4 (Sigma) for
30 min at room temperature in a humidified chamber. The
sections were then washed twice in 1× PBS (Sigma) for
5 min. Slides were then treated with a 1:500 dilution of
primary anti-alginate antibody (provided by Dr. Gerald
Pier, Harvard Medical School) in 1× PBS and placed in
a humidified chamber overnight at room temperature and
then washed twice in 1× PBS for 5 min and in distilled
water for 5 min. Slides were then treated with a 1:200 dilution of a secondary anti-rabbit antibody with a fluorescent
blue tag (405 nm, Thermo Scientific) for 1 h in a humidified chamber at room temperature. The sections were then
washed twice in 1× PBS for 5 min and in distilled water for
5 min. Sections were then washed in 0.2× SSC for 5 min
in the dark at room temperature. Sections were then counterstained with Sudan Black (Sigma) for 20 min. Sections
were mounted with PermaFluor (Thermo Scientific), and
images were captured using a Leica DM2500 fluorescent
microscope. As a negative control, all steps were repeated
with 200 ng of competing unlabeled oligonucleotide present during the hybridization.

5

Atomic force microscopy
The Borrelia/alginate-positive structures were visualized
at nanometer-scale resolution through atomic force microscopy (AFM) analyses. First, the biopsy section was
hydrated overnight at RT with 1× PBS (pH 7.4) buffer
and rinsed with double distilled water two times before
the scan. AFM scans on BL tissues were performed in
contact mode using the Nanosurf Easyscan 2 AFM (Nanosurf) with SHOCONG probe (AppNANO™). Images
were taken by Hamamatsu ORCA Digital Camera. Images
were processed, and measurements were obtained using
Gwyddion software.

Statistical analysis
Statistical analysis was performed using Student’s t-test
(Microsoft Excel, Redmond, WA) on the number of observed spirochetes and aggregates found in the 200 sections of the six BL specimens. Statistical significance was
determined based on p value <0.05.

Fig. 1. Representative immunohistochemical (IHC) images of borrelial lymphocytoma (BL) tissue sections stained with Borreliaspecific antibody following an IHC protocol as described earlier [41]. Positive Borrelia staining is depicted by red color. 200×
magnification, bar: 100 μm
European Journal of Microbiology and Immunology
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Results
Presence of Borrelia spirochetes and aggregates
in BL tissues sections
The overall goal of this study was to reexamine cutaneous cases of BL tissues to examine the potential presence
of Borrelia biofilms in vivo. First, six cases of borrelial
lymphocytoma archived tissues were retrieved from the
files of our Dermatohistopathologic Laboratory in the Department of Dermatology and Venereology, Medical University Innsbruck. Archival H&E-stained sections were
reexamined, and previous diagnoses were confirmed by
two of us (B.Z. and A.M.D.). The presence of Borrelia
was confirmed independently by two previously published
immunohistochemical methods [41] in Medical University
Innsbruck (Innsbruck, Austria) and in University of New
Haven (West Haven, CT) combined with silver staining
method performed in McClain Laboratory (Long Island,
NY). Figure 1 shows the representative images of the immunohistochemistry results of the six BL cases performed
in Medical University Innsbruck. In all BL cases, the pres-

ence of Borrelia spirochetes and aggregates was clearly
visible (red staining). Figure 1E and F show the presence
of Borrelia-positive aggregates which were the subject for
our further studies.
To further confirm the presence of Borrelia in the BL
tissues, modified Dieterle method silver staining techniques were performed independently in McClain histopathology laboratories (Smithtown, NY). Figure 2A shows
representative images of silver staining results on the BL
tissues sections demonstrating silver stain positive spirochetal structures (Fig. 2, panels Ai and iv) as well as different sizes of silver-stained positive aggregates (Fig. 2,
panels Aii and iii).
Aggregates which were positive for silver staining were
then subjected to additional studies by immunostaining at
the University of New Haven (West Haven CT, USA) of
the consecutive sections with a different Borrelia-specific
antibody to confirm that they are borrelial aggregates. Figure 2B shows that a silver-stained structure (can be found
in both panel Aiii and panel Bv), but not the “no antibody”
control (Fig. 2, panel Bvii), indeed stained positively with
Borrelia antibody (Fig. 2, panel Bvi, green fluorescent

Fig. 2. Representative images of borrelial lymphocytoma (BL) tissue sections stained with modified Dieterle silver methods and
Borrelia-specific IHC methods as described earlier [30]. White arrows in panel A show the silver-stained spirochetes (i and iv) and
aggregates (ii and iii), and panel B shows one of the silver-stained aggregates (panel Aiii) stained positive for Borrelia antigen. As a
negative control for the immunohistochemical method, panel Bvii shows a no antibody control on consecutive section, and panel Bviii
is the DIC image of the panel Bvii section to prove that there is still aggregate on the tissue section. 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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Fig. 3. A representative image shows a validation study for our 16S rDNA fluorescent in situ hybridization (FISH) protocol using different bacterial cells. The different bacterial cells placed on microscope slides and fixed and FISH protocols were carried out as described in Materials and methods section. The same FISH protocols were carried out on every experiment for Borrelia afzelii (panels
A and B), Borrelia garinii (panels C and D), Treponema denticola (panels E and F), Borrelia burgdorferi (panels G and H), Borrelia
hermsii (panels I and J), and Escherichia coli (panels K and L). DAPI nuclear stains depicting the cell morphology (panels B, D, F, H
J, and L). 400× magnification, bar: 100 μm

Fig. 4. Fluorescent in situ hybridization (FISH) of the BL tissues. Borrelia-specific 16S rDNA probe was utilized in these experiments
to localize Borrelia DNA (A). As comprehensive negative controls, a competing oligonucleotide (B), DNase-treated samples (C), and
a random DNA probe (D) were used on consecutive tissue sections to further show the specificity of the 16S rDNA probe (further
details of the experimental conditions are in Materials and methods section). The tissue morphology was demonstrated with DAPI
nuclear (E) and differential interphase contrast microscopy (DIC, panel F). 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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staining) on the consecutive slide. Figure 2, panel Bviii,
is a differential interference contract microscopy (DIC)
image of Fig. 2, panel Bvii, demonstrating that there is
still Borrelia aggregate on the slide despite the absence of
staining.
Fluorescence in situ hybridization (FISH) and PCR
further prove Borrelia DNA presence in BL tissues
To further confirm that the silver-stained aggregates observed in the BL tissues are indeed borrelial aggregates, we
performed FISH experiments using a B. burgdorferi sensu
lato-specific 16S rDNA probe. The specificity of our in
situ hybridization method was first confirmed using commercially available laboratory strains for B. burgdorferi,
B. garinii, B. afzelii, B. hermsii, T. denticola, and E. coli
(see Materials and methods section). Figure 3 shows that
all Borrelia species stained positive while non-Borrelia
species such as T. denticola and E. coli were found negative for Borrelia-specific DNA probe.
After validation of the experimental conditions with
laboratory strains, we have used this Borrelia-specific
FISH protocol on BL tissues sections. Figure 4 shows a

representative image of the FISH experiments that demonstrates that an aggregate found in BL tissues was successfully hybridized with Borrelia-specific 16S rDNA
probe without significant background noise (A). As comprehensive negative controls, a competing oligonucleotide
(B), DNase-treated samples (C), and a random probe (D)
experimental conditions were used on consecutive tissue
sections to show the specificity of the 16S rDNA FISH
probe. None of the negative control experimental conditions resulted in significant fluorescent signal, providing
evidence that the FISH experimental procedure is specific
for Borrelia DNA.
Further validation of the presence of Borrelia spp.
in the BL tissue biopsies was provided by extracting
the genomic DNA and amplifying B. burgdorferi sensu
lato-specific16S rDNA. Genomic DNA extracted from a
B. afzelii laboratory strain (BO23) was used as a positive
control, and no template control was used as negative
controls. Figure 5 demonstrates the result of the PCR
experiments demonstrating the expected PCR bands in
both the DNA extracted from the BL skin sections (S1–
S6) as well as in the laboratory strain positive control
(Fig. 5). No PCR products were seen in the no template
samples (−C), thus eliminating the possibility of contamination and, therefore, a nonspecific amplification in
the PCR reaction. All PCR products were sequenced and
analyzed by the BLAST program (NCBI) and identified
to have 99–100% identity to the B. afzelii 16S rDNA
gene compared to the B. afzelii K78 reference strain obtained from an Austrian cutaneous lesion, thus confirming the presence of B. afzelii DNA in our European BL
biopsies.

Presence of biofilm markers associated
with the aggregates in BL tissues

Fig. 5. Representative agarose gel picture of a Borrelia burgdorferi sensu lato specific 16S rDNA PCR amplification of genomic
DNAs obtained from borrelial lymphocytoma skin sections.
Lane M: 1 kb DNA Ladder (Life Technologies). Genomic DNA
extracted from Borrelia afzelii laboratory strain (positive control,
+C) and no template negative control (−C). Genomic DNAs extracted from borrelial lymphocytoma skin sections located in the
S1–S6 lanes. The bands seen in lanes of +C and S1–S6 (~450 bp)
represent DNA amplified using Borrelia-specific primers which
have a target size of 445 bp, indicating the presence of Borrelia
burgdorferi sensu lato DNA in the samples. No bands were seen
in the negative control (−C)
European Journal of Microbiology and Immunology

Having conclusively demonstrated the presence of Borrelia spirochetes and aggregates in BL tissues, we next
asked whether the Borrelia-positive aggregates found in
the BL tissue are biofilms. A hallmark characteristic of
biofilms is the presence of extracellular polysaccharides
which play major roles in protection, immune evasion,
and antibiotic resistance. We had previously shown that
the biofilms formed by various Borrelia species are rich
in mucopolysaccharides and share similarities with biofilms formed by other bacteria [32–39]. We characterized
the presence of mucopolysaccharides using an adaptation
of the Spicer & Meyer aldehyde fuchsine–alcian blue sequential staining method (see Materials and methods section), which can differentiate between sulfated and nonsulfated/carboxylated mucins. Fuchsia/purple coloration
indicates sulfated mucins while blue coloration indicates
non-sulfated/carboxylated mucins. Results of this staining method show that Borrelia-positive aggregates in BL
biopsies have similar staining pattern to the in vitro Borrelia aggregates found previously [30] staining for both
sulfated (fuchsia/purple) and non-sulfated (blue) mucins.
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Fig. 6. Representative images showing Spicer & Meyer aldehyde fuchsine–alcian blue sequential staining pattern of two aggregates
(white arrows) found in the BL tissues via dark field (panels A and C) and by differential interference contrast (panels B and D) microscopy methods. Fuchsia/purple colorations are indicative of sulfomucins and blue coloration indicates non-sulfated, carboxylated
mucins. 400× magnification, bar: 200 μm

Fig. 7. Representative images of IHC analyses of spirochetes and aggregates found in BL tissues costained with Borrelia (green) and
alginate (red) antibodies on the same tissue sections (panels A and B as well as D and E) or consecutive tissue section (panels G and H).
As negative control, the same IHC experiments were repeated on normal foreskin tissue sections (panels J and K). Differential interference contrast (DIC) images were provided to show the morphology of the tissues (panels C, F, I, and L). 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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Figure 6 shows the Spicer & Meyer staining pattern of two
representative aggregates (white arrows) found in the BL
biopsies by dark field (Fig. 6A and C) and DIC microscopy
methods (Fig. 6B and D). The images depicting all three
colors: fuchsia, purple, and blue indicate various mucopolysaccharides with different chemical composition on
the surface of Borrelia aggregates in the BL tissues.
Taken together, these results demonstrate that the aggregates found in BL tissues are Borrelia-positive by two
independently performed IHC and FISH techniques and
they do contain certain biofilm markers such as mucopolysaccharides on their surfaces. The blue coloration
on the surface of the aggregates indicated non-sulfated
mucins which strongly suggested alginate presence similarly to what we found on the surface of in vitro Borrelia
biofilms.
Borrelia aggregates, but not spirochetes,
strongly express alginates
In the following experiments, the goal was to confirm that
Borrelia aggregates indeed have alginate on their surfaces,
by different immunostaining methods using Borrelia- and
alginate-specific antibodies. Alginate antibody used in this
study was validated in our previous in vitro studies showing that it does not stain individual Borrelia spirochetes
as well as certain E. coli biofilms [30, 39]. As additional
independent control, we have also used 20 commercially purchased normal human foreskin sections. Figure 7
shows representative images of BL sections positively
costained with both Borrelia- and alginate-specific antibodies (Fig. 7A–B and D–E). We also repeated the double

staining experiments on consecutive slides using Borrelia
and alginate antibodies to demonstrate independent Borrelia and alginate stainings on the same biofilm (Fig. 7G
and H).
To further prove that the primary Borrelia- and alginate-specific antibodies do not have unspecific staining
on human skin tissue, we have repeated the above experiments on human foreskin sections (Fig. 7J and K). Also, all
individual spirochetes (Fig. 7A and D; white arrowheads)
were all alginate negative (Fig. 7B and E), a result, which
further demonstrates that alginate is specific to Borrelia
aggregates and the two antibodies used in these experiments do not cross-react.
In the next experiments, we repeated the IHC experiments with Borrelia- and alginate-specific antibodies using 1200 sections (200 sections/specimen). While the
majority of the sections contained at least one Borrelia
immunopositive spirochete (none of them stained for alginate), only ~5% of all the sections contained Borreliapositive aggregates with all different sizes. Figure 8 represents a summary graph of the number of the spirochetes
(ranging from 350 to 480 spirochetes/200 sections/specimen) and the number of aggregates (ranging from 4 to 12
aggregates/200 sections/specimen) observed in the six BL
tissues (BL1-BL6) as well as in the commercially purchased normal human foreskin tissue specimens (control).
There were no detectable Borrelia-positive spirochetes or
aggregates found in any of the control specimens. Statistical analyses of the number of spirochetes or aggregates
detected in the six BL tissues showed no significant differences among the specimens (p values >0.05).
IHC findings demonstrated that every Borrelia aggregate, but not any of the observed spirochete, was also posi-

Fig. 8. Graphical representation of the number of the spirochetes and the number of aggregates observed in 1200 sections of six BL
tissues (BL1-BL6; 200 sections/specimen) as well as in commercially purchased normal human foreskin tissue specimens (20 specimens). Y-axes data shows the number of the spirochetes (ranging from 350 to 480 spirochetes/200 sections/specimen) and the number
of aggregates (ranging from 4 to 12 aggregates/200 sections/specimen) found in the six BL tissue. There were no detectable spirochetes or aggregates found in any of the control specimens
European Journal of Microbiology and Immunology
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Fig. 9. Immunohistochemical staining of BL skin sections showing several different aggregates stained positive with Borrelia (green
staining: panels A, D, G, and J) and alginate specific antibodies (red staining: panels B, E, H and K). Differential interference microscopy (DIC) showing the size and tissue morphology of the skin tissues (panels C, F, I, and L). 400× magnification, bar: 200 μm

tive for alginate. Very importantly, nonspecific alginate
staining was not observed anywhere else in the BL skin
tissues. Figure 9 shows the heterogeneity in sizes of Borrelia aggregates in BL biopsies which were positive for
both Borrelia and alginate antigens.
Merged images show the localization of alginate associated with Borrelia-positive aggregates in sections which
were dual stained with both anti-Borrelia (green) and
anti-alginate (red) antibodies (Fig. 10, panels v and vi).
The yellow colored regions in the merged figures show regions, which contain both Borrelia and alginate antigens.
Bright field images showing the skin tissue stained with
Sudan black B (Fig. 10, panels vii and viii) show the size
and morphology of the skin tissue.

Combined FISH and IHC experiments further provide
evidence that Borrelia aggregates indeed express
alginate on their surfaces
Alternatively, the expression of alginate on the surface of
Borrelia-positive aggregates in BL skin tissues was also
detected using a combined FISH and IHC experiments
with 16S rDNA probe for Borrelia detection and alginate
antibody for alginate antigen detection. Figure 11 shows a
representative image which shows that a Borrelia-specific
FISH positive structure (A) stains for alginate (B) as well
as detected by IHC method. As a negative control, a competing oligonucleotide FISH was included to demonstrate
the specificity of the Borrelia FISH DNA probe (C).
European Journal of Microbiology and Immunology

12

E. Sapi et al.

Fig. 10. IHC staining of BL skin sections showing two different aggregates stained positive with Borrelia antigen (green staining:
panels i and ii) and alginate (red staining: panels iii and iv). Panels v and vi are a merge of the anti-Borrelia and anti-alginate antibody.
Panels vii and viii show the bright field image with Sudan Black-B staining. In the merged picture, yellow/light orange indicates the
regions where both Borrelia and alginate are present. 1000× magnification, bar: 200 μm

Fig. 11. Combined FISH and IHC representative image of Borrelia aggregates in BL skin tissues showing that Borrelia-DNA-positive
structures identified with FISH experiment using 16S rDNA probe (green staining, panel A) express alginate antibody (blue staining,
panel B) as depicted with an independent IHC method. To show that the structure indeed is Borrelia DNA positive, competing oligonucleotide was used as a negative control (panel C). Differential interference microscopy (DIC) showing the size and tissue morphology of the skin tissues (panel D). 400× magnification, bar: 200 μm
European Journal of Microbiology and Immunology
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Fig. 12. Three-dimensional atomic force microscopy analyses of Borrelia/alginate-positive aggregates from a BL biopsy tissue section. Panel A shows a representative image from the AFM analyses which was performed using contact mode of the Nanosurf Easyscan 2 AFM with SHOCONG probe (AppNANO™ [30]). Images were processed, and measurements were obtained using Gwyddion
software. The individual height and width ranges are indicated on the panels. Panel B shows evidence that the scanned tissue is Borrelia- and alginate-positive by fluorescent IHC analyses (400× magnification). Red arrows represent the same area of the tissue illustrated on panels A and B. Red and green arrowheads indicate potential channels and protrusions in the Borrelia/alginate-positive aggregates, bar: 200 μm

Ultra structural analysis of the Borrelia- and alginatepositive aggregates in BL biopsies by atomic force
microscopy (AFM)
Finally, to understand the ultrastructural organization of
Borrelia and alginate dual positive aggregates, we performed atomic force microscopy. Figure 12 shows representative micrographs of a dual stained Borrelia aggregate
costained with both Borrelia- and alginate-specific antibodies, which is deeply embedded in the surrounding tissues, observed using DIC microscopy (Fig. 12B). AFM
topographical scans also confirmed that the aggregates are
indeed embedded in the tissues (indicated by the red arrows) and have the characteristic channels and protrusions
that we observed in the in vitro Borrelia biofilms (red and
green arrowheads respectively) (Fig. 12A).

Discussion
We have previously provided evidence that B. burgdorferi
sensu stricto and sensu lato, the Lyme disease causing spirochete bacteria, are capable of forming biofilms in vitro
[30, 38]. The goal of this study was to find and characterize
potential Borrelia biofilms in vivo using infected skin tissues of BL biopsies from Austrian Lyme disease patients.
Our findings demonstrated that the observed aggregates
are indeed Borrelia-positive structures that express specific biofilm markers such as sulfated and non-sulfated
mucopolysaccharides which are mainly alginate. Our data
also demonstrated that the observed Borrelia-positive spirochetes do not express alginate which further support the
hypothesis that those Borrelia-positive aggregates are indeed biofilm structures. Our AFM studies further characEuropean Journal of Microbiology and Immunology
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terized the ultrastructure of Borrelia- and alginate-positive
aggregates and found additional biofilm characteristic
properties such as channels and protrusions of the tissueembedded biofilms.
Human biopsies used in this study were lesions from
BL from Lyme disease patients, a skin condition known
for the presence of Borrelia spirochetes and reported
mainly from Europe [42].
BL biopsies were previously analyzed for the different
morphological forms of Borrelia through focus-floating
microscopy methods [41]. Findings from this study revealed the presence of Borrelia spirochetes as clusters of
granular colonies. These descriptions are consistent with
an aggregate of organisms enmeshed in a matrix, similar
to the Borrelia biofilm found in vitro [30, 38]. To determine whether the Borrelia aggregates described in BL
biopsies are indeed biofilms, BL biopsy tissues from the
same archive collection were reexamined for biofilm-specific markers. Our results on human BL biopsy sections
first revealed the presence of Borrelia spirochetes and
aggregates by Borrelia-specific IHC methods combined
with additional silver staining, FISH techniques. To confirm the specificity of our techniques, we provided several independent negative controls for both the IHC and
FISH experiments such as: 1) the samples were analyzed
independently in European and in US laboratories respectively; 2) Borrelia and alginate IHC experiments were
performed on the same and sequential slides; 3) use of uninfected human foreskin samples and no antibody control
in the immunohistochemical experiments; 4) validation
of our FISH experiments with borrelial and non-borrelial
laboratory strains; 5) different in situ hybridization negative controls (competing oligonucleotide, random DNA
probes, and DNase-treated samples); and 6) combined
IHC–FISH experiments, which all provided evidence that
the results are indeed specific and do not represent background tissue staining.
Our findings also suggested that those Borrelia-positive aggregates, but not spirochetes, have several classical
features of biofilm structures because they were strongly
positive for different mucopolysaccharides as well as for
alginate, a negatively charged sugar polymer. Pseudomonas aeruginosa, the causative agent of cystic fibrosis,
forms biofilms rich in alginate that confer it protection
from the host immune system [33, 35, 45–47]. Studies further reported that these biofilms are very resistant to antibiotics and result in chronic inflammation and damage to
cystic fibrosis lung tissues. In other studies, however, it
was confirmed that even after the degradation of the alginate present on the biofilm surface, the gentamycin resistance of the biofilm was not affected [46]. This implies that
alginate might not be the only reason for the resistance of
biofilms and that there are other components which confer
antibiotic resistance. The exact role of alginate presence
on the surface on Borrelia aggregates in the infected skin
tissues still needs to be determined as well as the other potential protective layers indicated by our Spicer & Meyer
findings.
European Journal of Microbiology and Immunology

The presence of alginate on the Borrelia-positive structures in LB tissues also provides a good argument against
the theory called “amber hypothesis” which hypothesizes
that dead spirochetes and borrelial debris can persist in the
tissue and cause chronic inflammation in Lyme disease patients [48, 49]. The authors of these studies argued against
the idea of potential biofilm because the isolated Borrelia
aggregates found in mouse skin tissues failed to grow in
vitro. Culture negativity of biofilms from different pathogens is one of the cornerstone concepts for the behavior
of true biofilms [50, 51] as it was shown in biofilms in
culture-negative orthopedic and endocardiatic biofilm infections [51, 52] and therefore cannot be used to dismiss
the idea that Borrelia can make biofilm in vivo.
Among the order Spirochaetales, biofilms from T. denticola and Leptospira spp. have already been reported in
periodontal diseases and dental water systems, respectively [37, 53]. Further investigation of T. denticola biofilm
development revealed that it could be achieved in vitro
on fibronectin surfaces in a low-shear-force environment
[54]. We also found that certain surfaces are preferable for
Borrelia biofilm formation in vitro such as collagen and
fibronectin surfaces [30, 38], which correlates well with
the results from this study where Borrelia aggregates were
found in collagen- and fibronectin-rich skin tissues. Our
differential interference contrast and atomic force microscopy data also showed that the Borrelia biofilms embedded deeply in the tissue suggesting a potential host tissue
rearrangement during biofilm growth. The exact mechanism of host tissue remodeling during the dissemination of
B. burgdorferi is under active investigation and suggests
the use of a variety of bacterial factors and host enzymes;
therefore, it is very likely that those Borrelia aggregates
could use the same mechanism to embed the biofilm in the
tissues and further protect the structure from the host defense. Findings from this study could also raise the question about the kind of other tissues that could be potential
target for these Borrelia biofilm structures. In one of our
ongoing mouse studies, we have analyzed multiple tissue
sites in Borrelia-infected Balb/c mice model and found
in multiple tissues with similar Borrelia-positive aggregates with alginate presence [55]. We are also in the process studying the molecular mechanism of the antibiotic
resistance of Borrelia aggregates using different Borrelia
mutant cell lines and identified important pathways which
might be responsible for the observed resistance. For example, Lux S quorum sensing deficient Borrelia mutant
showed incomplete biofilm development and reduced resistance against certain antibiotics, a result which agrees
with the potential function of Lux S pathway during mammalian infection [56, 57].
In summary, in this study, we provided several lines of
evidence that Borrelia biofilm could exist in vivo. Further
confirmation and characterization of the presence of biofilm in vivo would help us better understand the survival
strategies of the Borrelia spp. within its host and would
provide important clinical data for therapeutic intervention
for Lyme disease patients.
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